期刊文献+

积极式个案管理对社区精神分裂症复发及卫生经济学影响 被引量:25

The effect of assertive case management on relapse and health economic evaluation in schizophrenics living in communities
暂未订购
导出
摘要 目的积极式个案管理模式(assertive case management,ACM)对社区精神分裂症患者疾病复发及卫生经济学指标的影响。方法 200例社区精神分裂症患者随机分为研究组(入组107例,完成107例)和对照组(入组93例,完成91例),分别接受ACM干预及进行自然观察,随访12个月。采用临床总体印象量表(clinical global impressions scale,CGI)、卫生经济学指标每3个月评估一次,采用药物依从性量表(medication adherence rating scale,MARS)在基线、3、6、12个月时分别进行评估,家庭负担量表(family burden instructing,FBI)在干预前后评估。结果研究组复发率(1.9%)低于对照组(11.0%),差异有统计学意义(P<0.01)。经重复测量方差分析,CGI-SI的时间主效应有统计学意义(P<0.01)。MARS因子1、因子3的时间主效应和组间主效应均有统计学意义(均P<0.05),因子1的交互作用有统计学意义(P<0.01),研究组的因子1评分不同时间之间有统计学差异(P<0.01)。两组间接成本、总费用的时间主效应有统计学意义(均P<0.05),直接成本、总费用的交互效应有统计学意义(P<0.05),研究组直接成本、总费用不同时间之间有统计学差异(均P<0.05)。两组干预前后FBI各维度的差值比较,研究组干预后对家庭关系影响分较对照组下降更明显(P<0.01)。结论 ACM模式能减少社区精神分裂症的复发,改善服药依从性,改善对家庭关系影响,减少治疗成本。 Objective To evaluate the effect of assertive case management on relapse and health economic evalua?tion in schizophrenics living in communities. Methods Two hundred outpatients were randomly divided into the study group (107 enrolled, 107 completed) which received assertive case management and the control group (93 enrolled, 91 completed) which received normal management treatment for 12 months. Clinical global impression scale (CGI) and the cost of treatment were assessed every three months. Medication adherence and family burden were evaluated before treat?ment and 3, 6 and 12 months after the treatment using Medication Adherence Rating Scale (MARS) and Family Burden Instructing, respectively. Results The study group was less likely to relapse compared with the control group over the 12-month follow-up and the relapse rates were 1.9%and 11.0%in study and control groups, respectively (P〈0.01). The repeated-measures analysis of variance indicated that time main effect was significant in severity of illness factor score of CGI (P〈0.01). The time main effect and group main effect in factor 1 and factor 3 scores of MARS were significant (all P〈0.05) and there was an interaction effect in factor1 score of MARS (P〈0.01). In the study group, time effect were signifi?cant in factor 1 score of MARS (P〈0.01). The time main effects in indirect cost and total cost were significant and so were interaction effects in direct cost and total cost (P〈0.05). In the study group, time effects were significant in direct cost and total cost (P〈0.01). Comparison of FBI dimensions before and after the intervention showed that family relation?ship was much more decreased in the study group than in the control group (P〈0.01). Conclusions Assertive Case Man?agement can reduce the recurrence of schizophrenia living in communities, improve compliance medication and family re?lationship as well as reduce the cost of treatment.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2014年第11期666-672,共7页 Chinese Journal of Nervous and Mental Diseases
基金 上海市公共卫生优秀学科带头人培养计划(编号:GWDTR201227) 国家自然科学基金(编号:81171272)
关键词 精神分裂症 积极式个案管理 复发 治疗成本 Schizophrenia Assertive Case Management Relapse The cost of treatment
  • 相关文献

参考文献23

  • 1李梓萌,潘超,卢天兰,阮燕燕,朱日升,王力芳,阎浩,岳伟华,张岱.精神分裂症患者探究性眼球轨迹运动与表皮生长因子4(ERBB4)基因多态性的关联[J].中国神经精神疾病杂志,2013,39(4):208-212. 被引量:5
  • 2HalesRE.精神病学教科书[M].张明园,主译.第1版.北京:人民卫生出版社,2010:279.
  • 3Low L, Tan YY, Lim BL, et al. Effectiveness of assertive com- munity management in Singapore[J]. Ann Acad Med Singapore, 2013, 42(3): 125-132.
  • 4吕钦谕,胡国芹,李君,吴国君,陈美娟,汪作为,吴晓波,易正辉,宋立升.积极式个案管理模式对精神分裂症患者生活质量影响的研究[J].神经疾病与精神卫生,2013(5):444-448. 被引量:15
  • 5Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new medication adherence rating scale (MARS) for the psy- choses[J]. Schizophrenia Res, 2000, 42(3): 241-247.
  • 6Fialko L, Garety PA, Kuipers E, et al. A large-scale validation study of the Medication Adherence Rating Scale (MARS)[J]. Schizophr Res, 2008, 100(1-3): 53-59.
  • 7张明园.精神分裂症的复发及其评估[J].中华精神科杂志,2012,45(1):4-6. 被引量:43
  • 8Lim CG, Koh CW, Lee C, et al. Community psychiatry in Singa- pore: a pilot assertive community treatment (ACT) programme [J]. Ann AcadMed Singapore, 2005, 34(1): 100-104.
  • 9Grawe RW, Falloon IRH, Widen JH, et al. Two years of contin- ued early treatment for recent-onset schizophrenia: a ran- domised controlled study[J]. Acta Psychiatr Scand, 2006, 114 (5): 328-336.
  • 10Sellwood W, Wittkowski A, Tarrier N, et al. Needs-basedcogni- tive-behavioural family intervention for patients suffering from schizophrenia: 5-year follow-up of a randomized controlled ef- fectiveness trial[J]. Acta Psychiatr Scand, 2007, 116(6): 447-452.

二级参考文献51

  • 1韩永华,王丽莉,朱日升,刘粹,周凤,吕淑艳,王秀丽,小岛卓也,松岛英介,沈渔村.精神分裂症和情感性精神障碍患者探究性眼球轨迹运动的比较[J].中国临床康复,2004,8(27):5868-5870. 被引量:2
  • 2潘超,韩永华,朱日升.首发精神分裂症患者探究性眼球轨迹运动研究[J].中国临床康复,2005,9(32):1-3. 被引量:4
  • 3郝伟.精神病学[M].5版.北京:人民卫生出版社,2005:119-122.
  • 4Gleeson JF, Alvarez-Jimenez M, Cotton SM, et al. A systematicreview of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis. Schizophr Res, 2010,119 ( 1-3 ) :79-88.
  • 5Wiersma D, Nienhuis FJ, Slooff C J, et al. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull, 1998,24:75-85.
  • 6方贻儒.精神分裂症的复发及其预防//江开达.精神医学新概念.上海:复旦大学出版社,2004:159-167.
  • 7Almond S, Knapp M, Francois C, et al. Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br J Psychiatry ,2004,184:346-351.
  • 8Andreasen NC, Carpenter WT Jr, Kane JM, et al. Remission in schizophrenia : proposed criteria and rationale for consensus. Am J Psychiatry, 2005,162:441-449.
  • 9Falloon IR. Relapse: a reappraisal of assessment of outcome in schizophrenia. Schizophr Bull, 1984,10:293-299.
  • 10Bebbington PE, Craig T, Garety P, et al. Remission and relapse in psychosis: operational definitions based on case-note data. Psychol Med,2006,36 : 1551-1562.

共引文献60

同被引文献242

引证文献25

二级引证文献286

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部